Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference21 articles.
1. Ghone A. Risk assessment in clinical trials—well Begun is half done. https://www.clinicalleader.com/doc/risk-assessment-in-clinical-trials-well-begun-is-half-done-0001
2. Aven T. Risk assessment and risk management: review of recent advances on their foundation. Eur J Oper Res. 2016;253:1–13.
3. U.S. Department of Health and Human Services Food and Drug Administration, E6 (R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1) Guidance for Industry ICH E6. https://www.fda.gov/downloads/Drugs/Guidances/UCM464506.pdf (2018).
4. Della-Coletta A, Katz T, Kupka K, et al. Toolkit for ICH E6 (R2) quality risk management for small to medium size companies. Ther Innov Regul Sci. 2020;54:900–21.
5. Liebig H, Hastings R. Reducing risk through mitigation strategies. Appl Clin Trials. 2009;20:1–10.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献